磷酸戊糖途径代谢转换诱导胰腺癌放射抵抗
研究通过递增剂量照射建立AsPC-1和MIAPaCa-2放射抵抗胰腺癌细胞模型,发现放射抵抗细胞过表达丙酮酸脱氢酶激酶、糖酵解增强、三羧酸循环和氧化磷酸化下调、磷酸戊糖途径通量增加及还原型谷胱甘肽水平升高。药理抑制磷酸戊糖途径可显著增强放射诱导的细胞死亡,放射联合6-氨基烟酰胺在体内协同抑制肿瘤生长。
要点
- 放射抵抗胰腺癌细胞过表达丙酮酸脱氢酶激酶并增强糖酵解。
- 放射抵抗细胞磷酸戊糖途径通量及还原型谷胱甘肽水平升高。
- 抑制磷酸戊糖途径可增强放射诱导的细胞死亡并协同抑制体内肿瘤生长。
核心结论
- 研究提供了胰腺导管腺癌放射抵抗代谢改变的机制理解,并证明通过代谢操作特别是抑制磷酸戊糖途径可使胰腺癌细胞对放射再敏感。
研究设计与样本
- 通过将AsPC-1和MIAPaCa-2人胰腺癌细胞暴露于递增剂量放射,建立两个匹配的放射抵抗胰腺导管腺癌细胞模型。
- 采用Nanostring技术、标记葡萄糖液相色谱-质谱追踪、Seahorse分析和代谢抑制剂暴露研究亲本与放射抵抗细胞的代谢谱。
- 在裸鼠皮下注射放射抵抗AsPC-1细胞建立的异种移植模型中评估放射联合磷酸戊糖途径抑制剂6-氨基烟酰胺的协同效应。
主要发现
- 放射抵抗细胞过表达丙酮酸脱氢酶激酶,并一致显示糖酵解增加、三羧酸循环和氧化磷酸化下调。
- 放射抵抗细胞磷酸戊糖途径代谢通量增加,还原型谷胱甘肽水平升高。
- 药理抑制磷酸戊糖途径显著增强放射诱导的细胞死亡。
- 放射联合磷酸戊糖途径抑制剂6-氨基烟酰胺在体内协同抑制肿瘤生长。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Pancreatic ductal adenocarcinoma (PDAC) is remarkably resistant to standard modalities, including radiotherapy. We hypothesized that metabolic reprogramming may underlie PDAC radioresistance, and moreover, that it would be possible to exploit these metabolic changes for therapeutic intent. METHODS AND MATERIALS: We established two matched models of radioresistant PDAC cells by exposing the AsPC-1 and MIAPaCa-2 human pancreatic cancer cells to incremental doses of radiation. The metabolic profile of parental and radioresistant cells was investigated using Nanostring technology, labeled-glucose tracing by liquid chromatography-mass spectrometry, Seahorse analysis and exposure to metabolic inhibitors. The synergistic effect of radiation combined with a pentose-phosphate pathway inhibitor, 6-aminonicotinamide (6-AN) was evaluated in a xenograft model established by subcutaneous injection of radioresistant-AsPC-1 cells into nude mice. RESULTS: The radioresistant cells overexpressed pyruvate dehydrogenase kinase (PDK) and consistently, displayed increased glycolysis and downregulated the tricarboxylic acid (TCA) cycle and oxidative phosphorylation. Metabolic flux through the pentose-phosphate pathway (PPP) was increased, as were levels of reduced glutathione; pharmacological inhibition of the PPP dramatically potentiated radiation-induced cell death. Furthermore, the combined treatment of radiation with the PPP inhibitor 6-AN synergistically inhibited tumor growth in-vivo. CONCLUSIONS: We provide a mechanistic understanding of the metabolic changes that underlie radioresistance in PDAC. Furthermore, we demonstrate that pancreatic cancer cells can be re-sensitized to radiation via metabolic manipulation, in particular, inhibition of the PPP. Exploitation of the metabolic vulnerabilities of radioresistant pancreatic cancer cells constitutes a new approach to pancreatic cancer, with a potential to improve clinical outcomes.
引用
- Shimoni-Sebag A, Abramovich I, Agranovich B, et al. A metabolic switch to the pentose-phosphate pathway induces radiation resistance in pancreatic cancer. Radiother Oncol. 2024. PMID: 39521275. doi:10.1016/j.radonc.2024.110606
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。